Momentum investing revolves around the idea of following a stock's recent trend in either direction. In "long context," investors will be essentially be "buying high, but hoping to sell even higher." With this methodology, taking advantage of trends in a stock's price is key; once a stock establishes a course, it is more than likely to continue moving that way. The goal is that once a stock heads down a fixed path, it will lead to timely and profitable trades.Even though momentum is a popular stock characte ...

Core Viewpoint - Momentum investing focuses on following a stock's recent price trends, aiming to buy high and sell higher, with the expectation that established trends will continue [1] Company Overview: TIM S.A. Sponsored ADR (TIMB) - TIMB currently holds a Momentum Style Score of A, indicating strong momentum characteristics [2] - The stock has a Zacks Rank of 1 (Strong Buy), suggesting a favorable outlook based on historical performance [3] Performance Metrics - Over the past week, TIMB shares increased by 2.31%, outperforming the Zacks Wireless Non-US industry, which rose by 1.36% [5] - In a longer timeframe, TIMB's monthly price change is 4.33%, compared to the industry's 1.77% [5] - Over the last quarter, TIMB shares have risen by 8.95%, and over the past year, they have increased by 62.13%, while the S&P 500 has only moved 3.76% and 14.96%, respectively [6] Trading Volume - TIMB's average 20-day trading volume is 433,489 shares, which serves as a baseline for price-to-volume analysis [7] Earnings Outlook - In the past two months, two earnings estimates for TIMB have been revised upwards, increasing the consensus estimate from $1.40 to $1.52 [9] - For the next fiscal year, one estimate has moved upwards with no downward revisions [9] Conclusion - Considering the strong performance metrics and positive earnings outlook, TIMB is positioned as a 1 (Strong Buy) stock with a Momentum Score of A, making it a potential candidate for near-term investment [11]

Core Viewpoint - Momentum investing focuses on "buying high and selling higher" rather than traditional strategies of "buying low and selling high" [1] Group 1: Momentum Investing Strategy - Momentum investors often face challenges in determining the right entry point for fast-moving stocks, which can lead to investments with limited upside or potential downside [2] - A safer approach may involve investing in bargain stocks that have recently shown price momentum, utilizing tools like the Zacks Momentum Style Score to identify promising candidates [3] Group 2: Case Study - Norsk Hydro ASA (NHYDY) - Norsk Hydro ASA (NHYDY) has shown a price increase of 3.8% over the past four weeks, indicating growing investor interest [4] - Over the past 12 weeks, NHYDY has gained 15%, demonstrating its ability to deliver positive returns over a longer timeframe [5] - NHYDY has a Momentum Score of A, suggesting it is an opportune time to invest in the stock [6] Group 3: Earnings Estimates and Valuation - NHYDY has received upward revisions in earnings estimates, earning a Zacks Rank 2 (Buy), which is associated with strong momentum effects [7] - The stock is currently trading at a Price-to-Sales ratio of 0.66, indicating it is attractively priced at 66 cents for each dollar of sales [7] Group 4: Additional Opportunities - NHYDY is not the only stock that meets the criteria of the 'Fast-Paced Momentum at a Bargain' screen, suggesting other potential investment opportunities exist [8] - Investors can explore over 45 Zacks Premium Screens tailored to different investing styles to identify winning stock picks [9]

Core Insights - Momentum investing focuses on following a stock's recent price trends, aiming to buy high and sell higher as stocks tend to continue in their established direction [1][2] - Argan (AGX) currently holds a Momentum Style Score of A and a Zacks Rank of 1 (Strong Buy), indicating strong potential for outperformance [2][3] Performance Metrics - Over the past week, AGX shares increased by 10.85%, outperforming the Zacks Building Products - Miscellaneous industry, which rose by 2.04% [5] - In the last quarter, AGX shares rose by 17.99%, and over the past year, they have surged by 124.51%, while the S&P 500 only increased by 7.07% and 16.3% respectively [6] Trading Volume - The average 20-day trading volume for AGX is 338,666 shares, which serves as a bullish indicator when combined with rising stock prices [7] Earnings Estimates - In the past two months, one earnings estimate for AGX has increased, raising the consensus estimate from $6.95 to $7.75 [9] - For the next fiscal year, one estimate has also moved upwards with no downward revisions noted [9] Conclusion - Given the strong performance metrics and positive earnings outlook, AGX is positioned as a promising investment opportunity with a Momentum Score of A [10][11]

Core Insights - Momentum investing focuses on following a stock's recent price trends, aiming to buy high and sell higher, with the expectation that established trends will continue [1] - Metagenomi (MGX) currently holds a Momentum Style Score of B, indicating a favorable momentum characteristic [2] - The Zacks Rank for Metagenomi is 1 (Strong Buy), suggesting strong potential for outperformance in the market [3] Price Performance - Over the past week, MGX shares have increased by 6.64%, while the Zacks Medical - Drugs industry remained flat [5] - In a longer timeframe, MGX has shown a monthly price change of 48.78%, significantly outperforming the industry's 0.1% [5] - Over the last three months, MGX shares have risen by 25.51%, and over the past year, they have gained 55.61%, compared to the S&P 500's increases of 6.14% and 15.41%, respectively [6] Trading Volume - The average 20-day trading volume for MGX is 1,206,561 shares, which serves as a bullish indicator when combined with rising stock prices [7] Earnings Outlook - In the past two months, one earnings estimate for MGX has increased, while none have decreased, leading to a consensus estimate improvement from -$2.42 to -$2.39 [9] - For the next fiscal year, one estimate has moved upwards with no downward revisions, indicating positive sentiment [9] Conclusion - Considering the positive price trends, trading volume, and earnings outlook, MGX is positioned as a 1 (Strong Buy) stock with a Momentum Score of B, making it a potential candidate for near-term investment [11]

Core Viewpoint - Momentum investing focuses on following a stock's recent price trends, aiming to buy high and sell higher, with the expectation that established trends will continue [1][2]. Company Overview: Xometry (XMTR) - Xometry currently holds a Momentum Style Score of B and a Zacks Rank of 2 (Buy), indicating strong potential for outperformance in the market [3][4]. - The company operates in the on-demand manufacturing sector, which shows promise as a solid momentum pick [4]. Price Performance - Over the past week, Xometry shares increased by 3.81%, while the Zacks Manufacturing - General Industrial industry saw a decline of 0.19% [6]. - In a longer timeframe, Xometry's shares have risen by 12.27% over the past month, significantly outperforming the industry's 0.75% [6]. - Over the last quarter, shares have surged by 47.59%, and over the past year, they have gained 197.62%, compared to the S&P 500's increases of 8.57% and 18.94%, respectively [7]. Trading Volume - Xometry's average 20-day trading volume is 768,045 shares, which serves as a bullish indicator when combined with rising stock prices [8]. Earnings Outlook - Recent earnings estimate revisions for Xometry have been positive, with three estimates moving higher for the current fiscal year, raising the consensus estimate from $0.30 to $0.35 [10]. - For the next fiscal year, four estimates have increased, with no downward revisions noted [10]. Conclusion - Considering the positive price trends, strong earnings outlook, and favorable trading volume, Xometry is positioned as a 2 (Buy) stock with a Momentum Score of B, making it a compelling option for investors seeking near-term gains [12].

Core Viewpoint - Momentum investing focuses on following a stock's recent price trends, aiming to buy high and sell higher, with the expectation that established trends will continue [1] Company Overview: Elbit Systems (ESLT) - Elbit Systems currently holds a Momentum Style Score of B, indicating a positive outlook based on price changes and earnings estimate revisions [2] - The company has a Zacks Rank of 2 (Buy), suggesting strong potential for outperformance in the market [3] Price Performance - Over the past week, ESLT shares increased by 1.15%, while the Zacks Aerospace - Defense Equipment industry rose by 1.72% [5] - In a longer timeframe, ESLT shares have gained 15.41% over the past quarter and 152% over the last year, significantly outperforming the S&P 500, which moved 8.12% and 17.38% respectively [6] Trading Volume - ESLT's average 20-day trading volume is 111,480 shares, which serves as a baseline for price-to-volume analysis [7] Earnings Outlook - In the last two months, one earnings estimate for ESLT has increased, raising the consensus estimate from $11.35 to $12.10 [9] - For the next fiscal year, one estimate has also moved upwards, with no downward revisions during the same period [9] Conclusion - Given the positive momentum indicators and earnings outlook, Elbit Systems is positioned as a strong candidate for investment, reflected in its 2 (Buy) rating and Momentum Score of B [11]

Company Overview - SiTime (SITM) currently holds a Momentum Style Score of B, indicating a positive momentum characteristic [2] - The company has a Zacks Rank of 2 (Buy), suggesting strong potential for outperformance in the market [3] Price Performance - Over the past week, SiTime shares have increased by 20.33%, significantly outperforming the Zacks Electronics - Miscellaneous Products industry, which rose by 1.48% [5] - The monthly price change for SiTime is 21.15%, compared to the industry's 3.06% [5] - In the last quarter, SiTime shares have risen by 38.3%, and over the past year, they have increased by 67.71%, while the S&P 500 has only moved 8.73% and 17.21% respectively [6] Trading Volume - SiTime's average 20-day trading volume is 373,288 shares, which is a useful indicator of market interest and can signal bullish or bearish trends [7] Earnings Estimates - In the past two months, three earnings estimates for SiTime have been revised upwards, with no downward revisions, leading to an increase in the consensus estimate from $1.60 to $2.22 [9] - For the next fiscal year, three estimates have also moved upwards without any downward revisions [9] Conclusion - SiTime is positioned as a 2 (Buy) stock with a Momentum Score of B, making it a strong candidate for investors seeking short-term gains [11]

Core Viewpoint - Momentum investing focuses on following a stock's recent price trends, aiming to buy high and sell higher, with the expectation that established trends will continue [1] Company Overview: Arcutis Biotherapeutics, Inc. (ARQT) - ARQT currently holds a Momentum Style Score of B, indicating potential as a solid momentum pick [3][12] - The company has a Zacks Rank of 2 (Buy), which is associated with a strong track record of outperformance [4][12] Performance Metrics - Over the past week, ARQT shares increased by 0.52%, while the Zacks Medical - Biomedical and Genetics industry remained flat [6] - In a longer timeframe, ARQT's monthly price change is 10.54%, significantly outperforming the industry's 0.92% [6] - Over the last quarter, ARQT shares rose by 25.73%, and over the past year, they increased by 90.11%, compared to the S&P 500's gains of 9.31% and 17.01%, respectively [7] Trading Volume - ARQT's average 20-day trading volume is 1,603,419 shares, which serves as a bullish indicator when combined with rising stock prices [8] Earnings Outlook - In the past two months, two earnings estimates for ARQT have been revised upwards, while none have been lowered, leading to an increase in the consensus estimate from -$0.55 to -$0.46 [10] - For the next fiscal year, two estimates have also moved upwards with no downward revisions [10]

Core Viewpoint - Momentum investing focuses on following a stock's recent price trends, aiming to buy high and sell even higher, with the expectation that established trends will continue [1] Group 1: Company Overview - Crexendo (CXDO) currently holds a Momentum Style Score of A, indicating strong momentum characteristics [2] - The company has a Zacks Rank of 2 (Buy), suggesting a favorable outlook based on historical performance of similar ranked stocks [3] Group 2: Performance Metrics - Over the past week, CXDO shares increased by 2.73%, outperforming the Zacks Internet - Services industry, which rose by 2.65% [5] - In a longer timeframe, CXDO shares have gained 14.43% over the past quarter and 42.68% over the last year, while the S&P 500 increased by 11.2% and 19.34%, respectively [6] Group 3: Trading Volume - The average 20-day trading volume for CXDO is 110,204 shares, which serves as a baseline for price-to-volume analysis [7] Group 4: Earnings Outlook - In the last two months, two earnings estimates for CXDO have been revised upwards, raising the consensus estimate from $0.29 to $0.33 [9] - For the next fiscal year, two estimates have also moved higher, with no downward revisions noted [9] Group 5: Conclusion - Considering all factors, CXDO is positioned as a 2 (Buy) stock with a Momentum Score of A, making it a potential candidate for near-term investment [11]